Name: 中东和非洲炭疽治疗市场规模、份额和趋势分析报告——2033年工业概况和预测
Creator: Data Bridge Market Research
License: https://www.databridgemarketresearch.com/privacy-policy

Middle East And Africa Anthrax Treatment Market

市场规模（十亿美元）

CAGR : 5.43 %

USD 43.50 Million USD 125.94 Million 2025 2033

Forecast Period	2026 –2033
Market Size (Base Year)	USD 43.50 Million
Market Size (Forecast Year)	USD 125.94 Million
CAGR	5.43 %
Major Markets Players	Pfize Inc.(美国) Bayer AG(德国) GlaxoSmithKline plc(英国) Sanofi(法国) Merck & Co.(美国)

中东和非洲炭疽治疗市场分化,按类型(阴性炭疽、肺上炭疽和肠道炭疽)、行政路线(Oral、Porderal等)、最终用户(政府组织、医院、学术和研究所等) -- -- 2033年工业趋势和预测

中东和非洲炭疽治疗市场概况

中东和非洲炭疽治疗市场2025年4350万美元预计将达到到2033年12.594亿美元,生长在一个2026年至2033年CAGR为5.43%50. 中东和非洲炭疽治疗市场正稳步增长,其动力是动物病意识的提高、牲畜依赖地区炭疽发作的发生率上升,以及政府扩大传染病监测和防备举措。新兴经济体对公共卫生基础设施和生物防御方案的投资不断增加,进一步支持了市场扩张。

农业工人、兽医和农村畜牧农牧区居民中炭疽感染的风险正在增加,同时加强疾病控制和疫苗接种方案的监管框架,这促使人们需要有效的治疗方法,包括抗生素、免疫球蛋白和辅助护理疗法。此外,诊断能力的提高和更快速的爆发反应机制正在鼓励早期发现和及时治疗,从而降低死亡率,并支持在整个中东和非洲区域持续采用炭疽疗法。

主要市场趋势和见解

沙特阿拉伯主导了中东和非洲炭疽治疗市场,2025年收入份额最大,为35.3%,得到强有力的保健基础设施的支持,政府越来越重视传染病的防备、先进的公共卫生监测系统以及对应急和生物防御方案的投资。
皮下炭疽部分在2025年占了58.42%的市场份额,原因是其流行率高于其他炭疽形式,而且诊断和治疗管理相对容易。
A.E.是该区域增长最快的国家,预计2026年至2033年将登记7.8%的CAGR,其动力是保健投资增加,先进诊断设施的扩大,对生物威胁防范的日益重视,以及加强传染病监测和应急能力。
由于越来越重视早期发现、关键护理准备和生物防御威胁的防范,预计肺炭疽是预测期间增长最快的分型。
2025年,父母管理途径主导了市场,其支持是其快速治疗行动和在医院紧急治疗协议中广泛使用严重炭疽感染。
医院是2025年最大的最终用户部分,其动力是提供特别护理设施和炭疽管理标准化治疗准则。

市场大小和预测

中东和非洲市场价值(2025):4,350万美元
预期市场价值(2033年):125.94万美元
CAGR预测(2026-2033):5.43%
2025年主要区域:沙特阿拉伯
最快增长区域: U.A.E.

范围与中东和非洲炭疽治疗市场分化

属性	炭疽治疗密钥市场透视
覆盖部分	按类型 :皮下炭疽、肺上炭疽和肠内炭疽按行政路线分列:口述、家长及其他按终端用户 :政府组织、医院、学术研究所等
涵盖国家	中东和非洲沙特阿拉伯 · 美国南非 • 埃及 • 以色列中东其他地区和非洲
关键市场玩家	• 辉瑞公司(美国) • Bayer AG(德国) • GlaxoSmithKline plc(英国) • 萨诺菲(法国) • 默克公司(美国) • Johnson & Johnson(美国) • AstraZeneca plc(英国) • Novartis AG(瑞士) • F. Hoffmann-La Roche有限公司(瑞士) • 西普拉有限公司(印度) • 太阳制药工业有限公司(印度) * Reddy博士实验室有限公司(印度) • 鲁平有限公司(印度) • Mylan N.V.(Viatris Inc.)(美国) • 泰瓦制药工业有限公司(以色列) • Eli Lily和Company(美国) • 武田制药有限公司(日本) • CSL有限公司(澳大利亚) • Biogen Inc.(美国) • 印度血清研究所 • Bharat生物技术国际有限公司(印度) • Aurobindo Pharma有限公司(印度) • Hetero实验室有限公司(印度) • Intas制药有限公司(印度) • Zydus生命科学有限公司(印度) • 阿伦比克制药有限公司(印度) • 尼古拉斯·皮拉马尔印度有限公司(印度) • 沃克哈特有限公司(印度) • 上海制药控股有限公司(中国) • 锡诺法尔集团有限公司(中国) • Takara Bio公司(日本) • 三菱田北制药公司(日本) • Otsuka制药有限公司(日本) • 卡肯制药有限公司(日本) • 桑多兹国际股份有限公司(瑞士) • 辉瑞澳大利亚私人有限公司(澳大利亚) • 韩国制药有限公司(韩国) • 韩美制药有限公司(韩国) • Celltrion公司(韩国)
市场机会	增加政府对传染病监测和生物防御方案的投资牲畜依赖区对有效炭疽治疗的需求增加诊断技术和定向治疗方法的进步
添加数据信息集的值	除了对市场价值,增长率,分化,地域覆盖,主要角色等市场情景的深刻认识外,由"数据桥市场研究"负责的市场报告还包括深入的专家分析,地域代表性的公司生产和能力,经销商和合作伙伴的网络布局,详细更新的价格趋势分析和供应链和需求赤字分析等.

中东和非洲炭疽治疗市场趋势

趋势:日益重视炭疽准备和先进治疗战略

政府、保健组织和研究机构正日益加强炭疽反应准备方案,因为其潜在影响是:炭疽杆菌公共卫生、牲畜管理和生物防御方面的感染。越来越强调快速诊断、有效抗生素的提供以及炭疽抗毒素疗法的发展,正在影响治疗市场的增长。先进的卫生保健系统正在采用经改进的诊断工作流程和治疗规程来降低与吸入炭疽等严重形式有关的死亡率。此外,增加对生物防御研究、疫苗研制和应急基础设施的投资正在支持全球对炭疽治疗办法的需求。

中东和非洲炭疽治疗市场动态

主要市场驱动力:增加政府在生物防御和传染病防备方面的投资

政府日益重视防范生物威胁,是全球炭疽治疗市场的一个主要驱动力。各国正在扩大抗生素、疫苗和炭疽抗毒素的战略储存,以确保在可能爆发或生物恐怖主义事件中作出快速反应。美国卫生与公众服务部等组织以及国家公共卫生机构都支持针对生物威胁的医疗对策的采购举措.

例如,在2023年3月 (中文(简体) ).制药公司和其他生物技术公司继续推进传染病和生物疗法研究,反映出业界对制定有针对性的治疗方法的更广泛兴趣。同样地,美国国家战略储存维持了包括抗生素和疫苗在内的重要医疗对策,以支持应对生物威胁的应急准备. 增加政府用于公共卫生安全的资金,特别是在全球传染病挑战之后,正在鼓励继续投资于炭疽治疗的开发和供应准备。

主要限制/挑战:有限的疾病发病率和高度发展的复杂性

全球炭疽治疗市场面临的一个主要挑战是,与其他传染病相比,自然出现的人类炭疽病例相对较少,这会限制对广泛开发药物的商业刺激。炭疽处理产品往往需要专门的研究、监管审批途径和注重生物防御的投资,从而增加发展的复杂性和成本。

此外,通过储存保持备战状态也给产品储存寿命、更换周期和库存管理带来挑战。制药公司必须兼顾持续提供炭疽对策的需要与不确定的需求模式,使市场扩张在很大程度上依赖于政府采购方案,而不是常规的临床需求.

主要市场机会:发展高级抗毒素、疫苗和有针对性的疗法

下一代炭疽疗法的开发为市场参与者提供了巨大的增长机会。单克隆抗体技术、重组疫苗和有针对性的抗微生物方法方面的进步正在提高治疗效果,特别是在涉及由毒素引起的并发症的严重感染方面。

例如,在2020年12月 (中文(简体) ).因此,Elusys治疗炭疽性炭疽抗毒素(obiltoxaximab)继续被认为是吸入炭疽治疗的重要医学对策,支持了抗毒素疗法与抗生素的作用. 此外,各国政府、生物技术公司和研究组织之间日益加强的合作正在加速生物防御治疗方面的创新。新兴市场,包括中东、非洲和中东各国,正在投资于保健基础设施和应急准备方案,为炭疽治疗制造商创造更多机会。

中东和非洲炭疽治疗市场范围

中东和非洲炭疽治疗市场按类型、管理路线和最终用户划分。

按类型

根据类型,中东和非洲炭疽治疗市场被分解为皮肤炭疽、肺炭疽和肠炭疽等。皮下炭疽部分在2025年占了58.42%的市场份额,原因是其流行率高于其他炭疽形式,而且诊断和治疗管理相对容易。在报告的感染中,阴道炭疽占大多数,特别是在牲畜接触严重、从事农业活动以及农民、兽医和动物饲养者面临职业风险的地区。这一部分得益于广泛提供抗生素疗法,包括口服和注射式治疗方案,以及提高对早期诊断和感染管理的认识。整个中东和非洲国家的政府疾病监测方案以及获得保健服务的机会的改善进一步支持了部分增长。

肺上炭疽部分预计将在2026至2033年达到6.8%的CAGR增长最快,其动力是日益重视先进的诊断能力、生物防御准备和严重炭疽感染的快速治疗方法。肺上炭疽因其高死亡率风险和与生物威胁的潜在联系而被认为是最严重的形式之一,从而产生了对专门治疗解决方案的需求. 预计增加对传染病防备、紧急保健基础设施和研究活动的投资将加快采用这一部门的先进治疗办法。

按行政路线分列

根据行政路线,中东和非洲炭疽治疗市场分为口服、父母口服等。 2025年,家长部分占了市场的52.67%,同时广泛使用可注射的抗生素和治疗方法治疗需要迅速采取药物行动和控制下治疗的严重炭疽病例。父母管理在医院和紧急医疗环境下得到广泛青睐,特别是对系统感染或疾病晚期的病人而言。与严重炭疽感染有关的住院率上升、保健基础设施的改善以及注射式抗微生物疗法的提供,都有助于这一阶层的强大市场地位。

预计口服部分在2026年至2033年期间将出现6.5%的最快CAGR,其动力是越来越多地采用方便的门诊治疗方法,以及越来越多地使用口服抗生素治疗早期和不太严重的炭疽感染。在农村和发展中地区扩大获得保健服务的机会,同时提高保健提供者对及时开始治疗的认识,正在支持部分增长。此外,口服治疗还提供一些好处,如易于施用、治疗复杂程度降低、病人遵守规定情况改善等,进一步刺激了中东和非洲市场的需求。

按终端用户

在最终用户的基础上,中东和非洲炭疽治疗市场分为政府组织、医院、学术研究所等。 2025年,由于医院在诊断、病人管理、急诊治疗和高级炭疽疗法的治疗方面发挥着中心作用,医院部分占了市场的46.35%。医院越来越多地采用改进的诊断工具、抗微生物治疗和感染控制规程来有效管理炭疽病例。此外,动物疫病负担日益加重,保健开支增加,整个中东和非洲国家的医疗基础设施得到加强,这些都支持医院在市场上占主导地位。

2026年至2033年,政府组织部分预计将看到最快的CAGR(7.1%),其动力是增加对公共卫生监测、疫情预防方案和生物防御举措的投资。政府机构正在集中力量加强疾病监测系统,改善应急准备,并确保在爆发期间提供炭疽治疗资源。此外,政府机构、保健机构和传染病控制研究组织之间的合作预计将为这一部门创造重大增长机会。

中东和非洲炭疽治疗市场区域分析

中东和非洲炭疽治疗市场预计将出现显著增长,其驱动力是政府日益重视传染病的防备,加强保健基础设施,增加对公共卫生监测和应急能力的投资。本区域各国正在通过改进保健系统、实验室网络和医疗对策举措,加强其早期发现、诊断和治疗炭疽的能力。越来越需要有效的抗生素、抗毒素疗法和疫情管理解决方案,这正在支持区域市场扩张。此外,对医院基础设施、生物技术研究和政府牵头的备灾方案的投资不断增加,有助于中东和非洲区域更多地采用炭疽治疗办法。

中国炭疽治疗市场透视

这个沙特阿拉伯炭疽治疗市场主导了中东和非洲区域,2025年最大的收入份额为35.3%。得到强有力的保健基础设施的支持,政府越来越重视传染病的防备,先进的公共卫生监测系统,以及对应急和生物防御方案的投资。包括抗生素、疫苗和抗毒素疗法。沙特阿拉伯正在扩大保健网络、医疗设施现代化以及政府以预防疾病和应急准备为重点的举措,进一步支持了市场增长。此外,保健组织、研究机构和政府机构之间在传染病监测和反应规划方面加强合作,可望加强全国各地炭疽治疗。

印度炭疽治疗市场透视

这个预计美国炭疽治疗市场将是中东和非洲区域增长最快的市场,2026至2033年的CAGR为7.8%,由不断增加的保健投资所驱动,扩大先进诊断设施,更加注重生物威胁防范,加强传染病监测和应急能力. 该国注重发展先进的保健基础设施、提高实验室能力以及采用现代疾病监测技术,正在支持炭疽治疗办法的增长。此外,对紧急医疗系统、生物技术研究以及公共卫生准备举措增加投资,正在增加先进治疗办法的提供和采用。政府组织越来越多地参与医疗保健安全方案、疫情应对规划和医疗准备举措,使美国成为本区域炭疽治疗的主要增长市场。

中东和非洲炭疽治疗市场份额

炭疽治疗行业主要由历史悠久的公司领导,其中包括:

辉瑞股份有限公司(美国)
拜耳公司(德国)
克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克克
萨诺菲(法国)
默克公司(美国)
约翰逊 & Johnson (美国).
AstraZeneca plc (英国).
诺华公司(瑞士)
F. Hoffmann-La Roche有限公司(瑞士)
西普拉有限公司(印度)
太阳制药工业有限公司(印度)
Reddy博士实验室有限公司(印度)
鲁平有限公司(印度)
Mylan N.V. (Viatris Inc.) (美国).
Teva制药工业有限公司(以色列)
Eli Lily and Company (美国).
武田制药有限公司(日本)
CSL有限公司(澳大利亚)
Biogen Inc. (美国).
印度血清研究所
Bharat生物技术国际有限公司(印度)
Aurobindo Pharma有限公司(印度)
赫特罗实验室有限公司(印度)
Intas制药有限公司(印度)
Zydus生命科学有限公司(印度)
阿伦比克制药有限公司(印度)
尼古拉斯·皮拉马尔印度有限公司(印度)
沃克哈特有限公司(印度)
上海制药控股有限公司(中国)
锡诺法尔集团有限公司(中国)
Takara Bio公司(日本)
三菱Tanabe Pharma公司(日本)
大冢制药有限公司(日本)
卡肯制药有限公司(日本)
桑多兹国际股份有限公司(瑞士)
辉瑞澳大利亚有限公司(澳大利亚)
韩国医药有限公司(韩国)
韩美制药有限公司(韩国)
Celltrion公司(韩国)

中东和非洲炭疽治疗市场的最新发展

2021年1月,美国食品药品管理局(FDA)批准了Anthim (obiltoxaximab)的标签更新,这是一种由Elusys治疗学开发的炭疽抗毒药物,将补充信息支持其使用,作为吸入炭疽治疗方法的一部分. Anthim是一种单克隆抗体疗法,旨在中和炭疽杆菌保护性抗原,并结合适当的抗菌药物使用. 对Anthim的持续监管支持加强了针对生物防御准备方案的抗毒素疗法的提供
2021年10月,生物医学高级研究开发局(BARDA)继续与生物技术公司合作,推进针对炭疽等生物威胁的医学对策. 这些举措侧重于通过研制、采购和储存疫苗、抗生素和抗毒素疗法来保持国家防范能力,以应对潜在的炭疽接触情况
2022年3月,美国政府在其"生物盾牌与战略国家库存计划"下扩大努力,以保持获得包括炭疽相关治疗和疫苗在内的关键医疗对策的机会. 该倡议通过确保提供紧急治疗和加强生物防御防范生物威胁,支持对炭疽治疗产品的持续需求
2022年9月,Emergent BioSolutions继续提供BioThrax(Anthrax Basincus Adsorbed),这是FDA批准的首个炭疽疫苗,用于美国政府的生物防御准备方案. 疫苗仍然是炭疽预防战略的关键组成部分,支持政府采购活动,加强炭疽防治在国家安全保健规划中的重要性
2023年4月,美国卫生与公众服务部(HHS)宣布继续通过BARDA投资医疗对策,以加强防范包括炭疽在内的生物威胁. 这些投资支持研究、开发、制造能力和提供快速应对可能爆发或蓄意生物事件所需的关键疗法
2023年11月,研究人员继续推进下一代炭疽治疗方法,包括以单克隆抗体为基础的治疗,并改进了旨在应对毒素介导疾病进展的抗微生物战略. 这些事态发展突出表明,人们日益重视可补充传统抗生素治疗的有针对性的疗法,特别是针对吸入性炭疽等严重形式的疗法。
2024年2月,Emergent BioSolutions宣布通过包括炭疽疫苗解决方案在内的涉及医疗对策的供应协议,继续支持美国政府的生物防御举措. 该公司的持续参与强调了可靠制造能力和长期提供炭疽预防产品对于国家备灾方案的重要性
2024年7月,美国政府继续通过"战略国家储备"开展与炭疽相关的医疗对策的采购活动,支持对炭疽疫苗,抗生素,抗毒素疗法的持续需求. 这些采购举措反映出越来越强调保持对生物紧急情况的准备,并改进应对能力
2025年3月,生物技术和公共卫生组织继续开展研究工作,重点是通过先进的生物研究平台改进炭疽诊断、治疗反应和生物防御准备。单克隆抗体、疫苗技术和快速诊断方法的持续创新支持了全球炭疽治疗生态系统的长期发展
2025年8月,全球生物防御方案继续强调综合炭疽预防战略,结合疫苗接种、抗生素疗法、抗毒素供应和应急规划。日益重视生物威胁管理,支持继续对炭疽治疗办法进行投资,并加强参与传染病防治的制药和生物技术公司的市场机会。

SKU-68921

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 POPULATION AT RISK (IN MILLIONS) BY REGION, LAND USE AND OCCUPATIONAL EXPOSURE, 2020-

TABLE 2 VACCINES IN DEVELOPMENT

TABLE 3 ANTIBIOTIC CONSUMPTION ESTIMATES BY GBD SUPER-REGION AND GBD REGION, FOR THE YEAR 2018-

TABLE 4 COUNTRY DATA OF ANTIBIOTICS CONSUMPTION-

TABLE 5 RECENT M&A IN ANTHRAX MARKET-

TABLE 6 ANTIBIOTICS MEDICINES

TABLE 7 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 8 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET, TYPE, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA CUTANEOUS ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA PARENTERAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA ORAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA GOVERNMENT ORGANIZATION IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA HOSPITALS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 48 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 49 MIDDLE EAST AND AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 52 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 53 MIDDLE EAST AND AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 55 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 56 MIDDLE EAST AND AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 58 MIDDLE EAST AND AFRICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 59 MIDDLE EAST AND AFRICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 63 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 64 MIDDLE EAST AND AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 67 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 68 MIDDLE EAST AND AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 70 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 71 MIDDLE EAST AND AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 73 MIDDLE EAST AND AFRICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 74 MIDDLE EAST AND AFRICA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 78 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 79 MIDDLE EAST AND AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 82 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 83 MIDDLE EAST AND AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 85 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 86 MIDDLE EAST AND AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 88 MIDDLE EAST AND AFRICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 89 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 91 SOUTH AFRICA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 92 SOUTH AFRICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 93 SOUTH AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 94 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 95 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 96 SOUTH AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 99 SOUTH AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 101 SOUTH AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 103 SOUTH AFRICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 SOUTH AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 105 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 106 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 107 SOUTH AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 108 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 109 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 110 SOUTH AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 111 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 112 SOUTH AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 113 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 114 SOUTH AFRICA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 115 SOUTH AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 117 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 118 SOUTH AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 121 SOUTH AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 123 SOUTH AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 125 SOUTH AFRICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 126 SOUTH AFRICA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 127 SAUDI ARABIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 SAUDI ARABIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 129 SAUDI ARABIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 130 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 131 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 132 SAUDI ARABIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 133 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 134 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 135 SAUDI ARABIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 136 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 137 SAUDI ARABIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 138 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 139 SAUDI ARABIA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 140 SAUDI ARABIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 141 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 142 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 143 SAUDI ARABIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 146 SAUDI ARABIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 148 SAUDI ARABIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 149 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 150 SAUDI ARABIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 SAUDI ARABIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 153 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 154 SAUDI ARABIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 155 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 156 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 157 SAUDI ARABIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 158 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 159 SAUDI ARABIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 160 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 161 SAUDI ARABIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 162 SAUDI ARABIA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 163 U.A.E ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 U.A.E CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 U.A.E ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 168 U.A.E BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 169 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 170 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 171 U.A.E ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 172 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 173 U.A.E VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 174 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 175 U.A.E PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 176 U.A.E ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 177 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 178 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 179 U.A.E BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 180 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 181 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 182 U.A.E ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 183 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 184 U.A.E VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 185 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 186 U.A.E INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 U.A.E ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 190 U.A.E BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 191 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 192 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 193 U.A.E ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 194 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 195 U.A.E VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 196 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 197 U.A.E ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 198 U.A.E ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 199 EGYPT ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 200 EGYPT CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 201 EGYPT ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 202 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 203 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 204 EGYPT BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 205 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 206 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 207 EGYPT ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 208 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 209 EGYPT VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 211 EGYPT PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 EGYPT ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 213 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 214 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 215 EGYPT BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 216 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 217 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 218 EGYPT ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 219 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 220 EGYPT VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 221 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 222 EGYPT INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 223 EGYPT ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 224 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 225 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 226 EGYPT BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 227 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 228 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 229 EGYPT ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 231 EGYPT VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 233 EGYPT ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 234 EGYPT ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 235 ISRAEL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 ISRAEL CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 237 ISRAEL ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 238 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 239 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 240 ISRAEL BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 241 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 242 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 243 ISRAEL ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 244 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 245 ISRAEL VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 246 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 247 ISRAEL PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 248 ISRAEL ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 249 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 250 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 251 ISRAEL BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 254 ISRAEL ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 255 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 256 ISRAEL VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 258 ISRAEL INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 259 ISRAEL ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 260 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 261 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 262 ISRAEL BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 263 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 264 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 265 ISRAEL ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 266 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 267 ISRAEL VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 268 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 269 ISRAEL ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 270 ISRAEL ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 271 REST OF MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 11 MIDDLE EAST & AFRICA IS ANTICIPATED TO DOMINATE THE ANTHRAX TREATMENT MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASING INCIDENCE AND PREVALENCE OF ANTHRAX INFECTIONS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET IN THE FORECAST PERIOD

FIGURE 13 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET IN 2022 & 2029

FIGURE 14 MIDDLE EAST & AFRICA DISTRIBUTION OF OUTBREAKS BY COUNTRY AND GEOGRAPHIC LOCATIONS OF ANTHRAX EVENTS-

FIGURE 15 PATHOPHYSIOLOGY OF ANTHRAX-

FIGURE 16 FLOW CHART FOR SUSPECTED ANTHRAX EXPOSURE-

FIGURE 17 GC BIOPHARMA ANTHRAX CANDIDATE GC1109 IS IN PHASE 2 (NCT01624532).

FIGURE 18 BA-ISTAB IS A FUSION OF A B. ANTHRACIS SPECIFIC CWT WITH A POTENT MONOCLONAL ANTIBODY THAT NEUTRALIZE ANTHRAX TOXIN (PA).

FIGURE 19 TWO ROUTES BY WHICH VACCINATION CAN REDUCE INCIDENCE OF AMR-

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET

FIGURE 21 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, 2021

FIGURE 22 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, 2022-2029 (USD MILLION)

FIGURE 23 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, CAGR (2022-2029)

FIGURE 24 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, LIFELINE CURVE

FIGURE 25 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2021

FIGURE 26 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 27 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 28 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, 2021

FIGURE 30 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 31 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, CAGR (2022-2029)

FIGURE 32 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, LIFELINE CURVE

FIGURE 33 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: SNAPSHOT (2021)

FIGURE 34 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2021)

FIGURE 35 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2022 & 2029)

FIGURE 36 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2021 & 2029)

FIGURE 37 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY TYPE (2022-2029)

FIGURE 38 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: COMPANY SHARE 2021(%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。